JP7165618B2 - アレルギー性鼻炎のリスクを判定する方法 - Google Patents

アレルギー性鼻炎のリスクを判定する方法 Download PDF

Info

Publication number
JP7165618B2
JP7165618B2 JP2019081986A JP2019081986A JP7165618B2 JP 7165618 B2 JP7165618 B2 JP 7165618B2 JP 2019081986 A JP2019081986 A JP 2019081986A JP 2019081986 A JP2019081986 A JP 2019081986A JP 7165618 B2 JP7165618 B2 JP 7165618B2
Authority
JP
Japan
Prior art keywords
snp
disease
genotype
risk
model
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019081986A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020178563A5 (https=
JP2020178563A (ja
Inventor
ヨスバニ 宇田川
鶴 黄
バラン 伊里 佐藤
Original Assignee
ジェネシスヘルスケア株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジェネシスヘルスケア株式会社 filed Critical ジェネシスヘルスケア株式会社
Priority to JP2019081986A priority Critical patent/JP7165618B2/ja
Publication of JP2020178563A publication Critical patent/JP2020178563A/ja
Publication of JP2020178563A5 publication Critical patent/JP2020178563A5/ja
Application granted granted Critical
Publication of JP7165618B2 publication Critical patent/JP7165618B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2019081986A 2019-04-23 2019-04-23 アレルギー性鼻炎のリスクを判定する方法 Active JP7165618B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019081986A JP7165618B2 (ja) 2019-04-23 2019-04-23 アレルギー性鼻炎のリスクを判定する方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019081986A JP7165618B2 (ja) 2019-04-23 2019-04-23 アレルギー性鼻炎のリスクを判定する方法

Publications (3)

Publication Number Publication Date
JP2020178563A JP2020178563A (ja) 2020-11-05
JP2020178563A5 JP2020178563A5 (https=) 2022-03-15
JP7165618B2 true JP7165618B2 (ja) 2022-11-04

Family

ID=73022541

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019081986A Active JP7165618B2 (ja) 2019-04-23 2019-04-23 アレルギー性鼻炎のリスクを判定する方法

Country Status (1)

Country Link
JP (1) JP7165618B2 (https=)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060073492A1 (en) 2004-06-04 2006-04-06 Sarma Puranam U Prediction and predisposition of MBL gene to bronchial asthma with allergic rhinitis
US20090297563A1 (en) 2004-10-27 2009-12-03 Anders Borglum Diagnosis And Treatment of Immune-Related Diseases
CN105950738A (zh) 2016-05-27 2016-09-21 福建爱我健康生物科技有限公司 一种用于评估皮肤抗过敏情况的引物和探针及试剂盒
WO2018190990A1 (en) 2017-04-13 2018-10-18 Regeneron Pharmaceuticals, Inc. Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding il33 and il1rl1

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060073492A1 (en) 2004-06-04 2006-04-06 Sarma Puranam U Prediction and predisposition of MBL gene to bronchial asthma with allergic rhinitis
US20090297563A1 (en) 2004-10-27 2009-12-03 Anders Borglum Diagnosis And Treatment of Immune-Related Diseases
CN105950738A (zh) 2016-05-27 2016-09-21 福建爱我健康生物科技有限公司 一种用于评估皮肤抗过敏情况的引物和探针及试剂盒
WO2018190990A1 (en) 2017-04-13 2018-10-18 Regeneron Pharmaceuticals, Inc. Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding il33 and il1rl1

Also Published As

Publication number Publication date
JP2020178563A (ja) 2020-11-05

Similar Documents

Publication Publication Date Title
JP7140707B2 (ja) 緑内障のリスクを判定する方法
JP6688418B1 (ja) ２型糖尿病のリスクを判定する方法
JP7106489B2 (ja) 脂肪肝のリスクを判定する方法
JP7161442B2 (ja) リウマチのリスクを判定する方法
JP7165098B2 (ja) 動脈硬化のリスクを判定する方法
JP7165099B2 (ja) 心筋梗塞及び／又は狭心症のリスクを判定する方法
JP7165617B2 (ja) 高血圧のリスクを判定する方法
JP7137525B2 (ja) 接触性皮膚炎のリスクを判定する方法
JP7165618B2 (ja) アレルギー性鼻炎のリスクを判定する方法
JP7165100B2 (ja) 心房細動及び／又は心室細動のリスクを判定する方法
JP7161443B2 (ja) 尿管結石及び／又は腎結石のリスクを判定する方法
JP7138075B2 (ja) 甲状腺機能低下症のリスクを判定する方法
JP7108574B2 (ja) アレルギー性結膜炎のリスクを判定する方法
JP7165619B2 (ja) 慢性気管支炎のリスクを判定する方法
JP7138077B2 (ja) 卵巣がん及び／又は子宮がんのリスクを判定する方法
JP7106490B2 (ja) 胆石のリスクを判定する方法
JP7137524B2 (ja) 変形性膝関節症のリスクを判定する方法
JP7160750B2 (ja) 骨粗しょう症のリスクを判定する方法
JP7161440B2 (ja) 気管支ぜんそくのリスクを判定する方法
JP7108573B2 (ja) 慢性中耳炎のリスクを判定する方法
JP7107886B2 (ja) 虫歯のリスクを判定する方法
JP7137519B2 (ja) 結核のリスクを判定する方法
JP7107884B2 (ja) 食物アレルギーのリスクを判定する方法
JP7137523B2 (ja) じんましんのリスクを判定する方法
JP7138073B2 (ja) 注意欠陥多動性症候群のリスクを判定する方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200609

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220304

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220629

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220728

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20221003

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20221024

R150 Certificate of patent or registration of utility model

Ref document number: 7165618

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250